# Effect of platelet rich plasma injection on bone formation in the expanded mid-palatal suture in rabbits: a randomized controlled animal study

**Authors:** Sherief H. Abdel-Haffiez, Nesma Mohamed Khalil

PMC · DOI: 10.1186/s12903-024-03922-6 · BMC Oral Health · 2024-02-02

## TL;DR

This study shows that injecting platelet-rich plasma in rabbits speeds up bone formation in the mid-palatal suture, potentially reducing the need for long retention periods after expansion.

## Contribution

The study demonstrates that PRP injection accelerates bone formation in the expanded mid-palatal suture in rabbits.

## Key findings

- PRP injection significantly increased new bone formation (14.4%) compared to the control (1.4%).
- The suture width in the PRP group was significantly wider than in the control group.
- PRP increased vascular density and osteopontin expression, indicating enhanced bone healing.

## Abstract

Mid-Palatal suture expansion needs long retention period due to delayed bone formation in the expanded suture. Platelet-rich plasma (PRP) is a concentrated source of growth factors which increase bone formation. The aim of this study was to evaluate the effect of PRP injection on bone formation in expanded mid palatal suture in rabbits.

In this prospective randomized controlled animal study, Twenty male rabbits (8-weeks-old) were subjected to mid-palatal expansion for 5 days. Animals were afterwards randomly divided into control group A & study group B. PRP was prepared and injected in the mid-palatal suture in animals belonging to group B only. After 6 weeks of retention, all animals were euthanized, and premaxillae were prepared for histological, histomorphometric and immunohistochemical analysis. Student t-test and paired t-test were used to compare the means of the two groups and within the same group respectively. Significance level set at p ≤ 0.05.

Histomorphometric analysis revealed a significant increase (p < 0.001) in the mean percentage of new bone in the study group (14.4%) compared to the control (1.4%). Suture width in study group was significantly wider than the control group (278.8 ± 9μms and 120.4 ± 3.4μms, p < 0.001). There was a significant increase in vascular density in study group than control group (309 ± 65.34 and 243.86 ± 48.1, p = 0.021). Osteopontin immuno-expression revealed a significant increase in optical density in study group than control group (0.21 ± 0.02 & 0.12 ± 0.01, p < 0.001).

In rabbit model, PRP injection can accelerate new bone formation in the expanded mid-palatal suture when compared to the control. This could hopefully result in a more stable midpalatal expansion and a reduced retention period.

## Linked entities

- **Species:** Oryctolagus cuniculus (taxon 9986)

## Full-text entities

- **Genes:** Osteopontin [NCBI Gene 100008982], osteocalcin [NCBI Gene 100340503], osteoprotegerin [NCBI Gene 100348133], TGF beta1 [NCBI Gene 100008645], Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Cd34 (CD34 molecule) [NCBI Gene 305081]
- **Diseases:** Platelet Rich Plasma (MESH:D000080203), osteoid (MESH:D010017), Maxillary constriction (MESH:D008439), bone defect (MESH:D001847), palate (MESH:D002972), blood coagulation (MESH:D001778), bony defects (MESH:D018213), inflammatory (MESH:D007249), PDAF (MESH:C566798), infections (MESH:D007239), fracture (MESH:D050723), H&amp;E (MESH:D016751), dermatological lesions (MESH:D000168), blood clot (MESH:D013927)
- **Chemicals:** citrate (MESH:D019343), Saline (MESH:D012965), water (MESH:D014867), sodium pentobarbital (MESH:D010424), formic acid (MESH:C030544), Hematoxylin and Eosin (-), 3,3'-Diaminobenzidine (MESH:D015100), calcium phosphate (MESH:C020243), lithium chloride (MESH:D018021), stainless steel (MESH:D013193), EDTA (MESH:D004492), boron (MESH:D001895), sodium citrate (MESH:D000077559), zoledronic acid (MESH:D000077211), alcohol (MESH:D000438), xylene (MESH:D014992), hematoxylin (MESH:D006416), ethanol (MESH:D000431), Phosphate (MESH:D010710), paraffin (MESH:D010232), Xylazine (MESH:D014991), i (MESH:D007455), heparin (MESH:D006493), bisphosphonates (MESH:D004164), Ketamine (MESH:D007649)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** i — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_AS22)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10835953/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10835953/full.md

## References

89 references — full list in the complete paper: https://tomesphere.com/paper/PMC10835953/full.md

---
Source: https://tomesphere.com/paper/PMC10835953